Latest News

A bacterium may limit cardiovascular risks of 1 in 2 people, study shows

In 2007, Patrice Cani (FNRS-WELBIO researcher) and his team at the Louvain Drug Research Institute of University of Louvain, in close collaboration with Willem de Vos, professor at UWageningen, discovered the beneficial effects of an intestinal bacteria, Akkermansia muciniphila, able to moderate the development of obesity and type 2 diabetes, in mice.

Source link

Related posts

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes


As Tick Bites Rise, So Do Meat Allergies


Researchers find neural cells in rat brain that are tuned to posture


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy